Insiders Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:56 2024-05-17 am EDT			5-day change	1st Jan Change
600 ^DKK	-2.99%		-8.75%	+60.77%

May. 16	Nordic Stocks Declined Thursday; Zealand Pharma Took Biggest Hit	DJ
May. 16	Transcript : Zealand Pharma A/S, Q1 2024 Earnings Call, May 16, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zealand Pharma A/S Approves Appointments to the Board	Mar. 20	CI
Zealand Pharma A/S Announces Board Changes	Mar. 13	CI
Zealand Pharma A/S Appoints Enrique Conterno and Elaine Sullivan as Board Observers	Nov. 30	CI
Zealand Pharma A/S Announces Committee Appointments	23-03-29	CI
Zealand Pharma Appoints New CFO	22-08-24	MT
Zealand Pharma Names Henriette Wennicke Finance Chief	22-08-24	MT
Zealand Pharma Names David Kendall Chief Medical Officer	22-06-02	MT
Zealand Pharma Announces Appoints David M. Kendall, as Chief Medical Officer	22-06-02	CI
Zealand Pharma Names New CEO, Cuts US Workforce by 90%; Releases Revised Guidance; Shares Rise	22-03-30	MT
Zealand Pharma Announces CEO Changes	22-03-30	CI
Zealand Pharma A/S Announces Executive Changes	21-09-01	CI
Gertrude Koefoed Rasmussen to Step Down from the Board of Zealand Pharma A/S, Effective as of 31 August 2021	21-08-13	CI
Zealand Pharma A/S Announces the Promotion of Christina Sonnenborg Bredal to Head of People & Organization	21-05-12	CI
Zealand Pharma A/S Establishes New Scientific Committee, Which Will Comprise of Kirsten Aarup Drejer as the Chair, Michael John Owen and Alain Munoz as Members of the Committee	21-04-15	CI
Zealand Pharma A/S : Nomination of proxy & postal vote form	21-03-18	PU
Zealand Pharma A/S Announces Management Appointments	20-09-04	CI
Zealand Pharma A/S Appoints Mads Kronborg as Head of Investor Relations & Communication	20-08-03	CI
Zealand Pharma U.S. Appoints Frank Sanders as President	20-06-15	CI
Zealand Pharma A/S Announces Board Changes	20-04-03	CI
Zealand Pharma A/S Appoints Matthew Dallas as Vice President and Chief Financial Officer, Effective October 7, 2019	19-08-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Insiders

Filters